연구성과로 돌아가기
2025 연구성과별 연구자 정보 (901 / 1187)
※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Document Title | Author Full Name | Author Short Name | Index | Corresponding | Address | ResearcherID | ResearcherID Author Name | ORCID | ORCID Author Name | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
| Real-world effectiveness of ixazomib, lenalidomide and dexamethasone in Asians with relapsed/refractory multiple myeloma | Jung, Sung Hoon | Jung, SH | 8 | Chonnam Natl Univ, Hwasun Hosp, Dept Hematol & Oncol, Hwasun, South Korea | kihyunkimk@gmail.com; supornch@gmail.com; | |||||
| Real-world effectiveness of ixazomib, lenalidomide and dexamethasone in Asians with relapsed/refractory multiple myeloma | Do, Young Rok | Do, YR | 9 | Keimyung Univ, Dongsan Med Ctr, Div Hemato Oncol, Daegu, South Korea | kihyunkimk@gmail.com; supornch@gmail.com; | |||||
| Real-world effectiveness of ixazomib, lenalidomide and dexamethasone in Asians with relapsed/refractory multiple myeloma | Wilfred, Gilbert | Wilfred, G | 10 | Hosp Queen Elizabeth, Dept Med, Kota Kinabalu, Malaysia | kihyunkimk@gmail.com; supornch@gmail.com; | |||||
| Real-world effectiveness of ixazomib, lenalidomide and dexamethasone in Asians with relapsed/refractory multiple myeloma | Husin, Azlan | Husin, A | 11 | Univ Sains Malaysia, Dept Internal Med, George Town, Gelugor, Malaysia | P-4040-2019 | Husin, Azlan | kihyunkimk@gmail.com; supornch@gmail.com; | |||
| Real-world effectiveness of ixazomib, lenalidomide and dexamethasone in Asians with relapsed/refractory multiple myeloma | Kim, Hyo Jung | Kim, HJ | 12 | Hallym Univ, Dept Internal Med, Sacred Heart Hosp, Anyang, South Korea | kihyunkimk@gmail.com; supornch@gmail.com; | |||||
| Real-world effectiveness of ixazomib, lenalidomide and dexamethasone in Asians with relapsed/refractory multiple myeloma | Wahid, Sfadilah Abdul | Wahid, SA | 13 | Hosp Canselor Tuanku Muhriz, Pusat Terapi Sel, Kuala Lumpur, Malaysia | kihyunkimk@gmail.com; supornch@gmail.com; | |||||
| Real-world effectiveness of ixazomib, lenalidomide and dexamethasone in Asians with relapsed/refractory multiple myeloma | Lee, Myung-Won | Lee, MW | 14 | Chungnam Natl Univ Hosp, Dept Internal Med, Daejeon, South Korea | kihyunkimk@gmail.com; supornch@gmail.com; | |||||
| Real-world effectiveness of ixazomib, lenalidomide and dexamethasone in Asians with relapsed/refractory multiple myeloma | Heo, Hye-won | Heo, HW | 15 | Takeda Pharmaceut Korea Co Ltd, Med Affairs, Seoul, South Korea | kihyunkimk@gmail.com; supornch@gmail.com; | |||||
| Real-world effectiveness of ixazomib, lenalidomide and dexamethasone in Asians with relapsed/refractory multiple myeloma | Kim, Kihyun | Kim, K | 16 | 교신저자 | Sungkyunkwan Univ, Samsung Med Ctr, Dept Med, Sch Med, Seoul, South Korea | kihyunkimk@gmail.com; supornch@gmail.com; | ||||
| Real-world effectiveness of ixazomib, lenalidomide and dexamethasone in Asians with relapsed/refractory multiple myeloma | Chuncharunee, Suporn | Chuncharunee, S | 17 | 교신저자 | Ramathibodi Hosp, Dept Internal Med, Bangkok, Thailand | kihyunkimk@gmail.com; supornch@gmail.com; | ||||
| Reassessing the Role of the Neurofilament Light Chain in Guillain-Barre Syndrome: Issues in Diagnosis and Subgroup Classification | Seok, Hung Youl | Seok, HY | 1 | Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Neurol, Daegu, South Korea | HZI-4365-2023 | Seok, Hung Youl | eunmiyn@gmail.com; | |||
| Reassessing the Role of the Neurofilament Light Chain in Guillain-Barre Syndrome: Issues in Diagnosis and Subgroup Classification | Eun, Mi-Yeon | Eun, MY | 2 | 교신저자 | Kyungpook Natl Univ, Kyungpook Natl Univ Chilgok Hosp, Sch Med, Dept Neurol, Daegu, South Korea | AAV-2877-2021 | Eun, Mi-Yeon | 0000-0002-8617-5850 | Eun, Mi-Yeon | eunmiyn@gmail.com; |
| Rebamipide (Mucosta®), a clinically approved drug, alleviates neuroinflammation and dopaminergic neurodegeneration in a Parkinson's disease model | Lim, Hye-Sun | Lim, HS | 1 | Korea Inst Oriental Med, Herbal Med Resources Res Ctr, 111 Geonjae Ro, Naju 58245, Jeollanam Do, South Korea | qp1015@kiom.re.kr; jypark@naver.com; eunjkim@knu.ac.kr; wonhwalee@skku.edu; hyyun@cnu.ac.kr; passion_lsh@cnu.ac.kr; gpark@kiom.re.kr; | |||||
| Rebamipide (Mucosta®), a clinically approved drug, alleviates neuroinflammation and dopaminergic neurodegeneration in a Parkinson's disease model | Park, Jinyoung | Park, J | 2 | Sungkyunkwan Univ, Dept Chem, Suwon 16419, South Korea | qp1015@kiom.re.kr; jypark@naver.com; eunjkim@knu.ac.kr; wonhwalee@skku.edu; hyyun@cnu.ac.kr; passion_lsh@cnu.ac.kr; gpark@kiom.re.kr; | |||||
| Rebamipide (Mucosta®), a clinically approved drug, alleviates neuroinflammation and dopaminergic neurodegeneration in a Parkinson's disease model | Kim, Eunjeong | Kim, E | 3 | Kyungpook Natl Univ, KNU Inst Basic Sci, BK21 FOUR KNU Creat BioRes Grp, Dept Biol,KNU G LAMP Res Ctr,Coll Nat Sci, Daegu 41566, South Korea | qp1015@kiom.re.kr; jypark@naver.com; eunjkim@knu.ac.kr; wonhwalee@skku.edu; hyyun@cnu.ac.kr; passion_lsh@cnu.ac.kr; gpark@kiom.re.kr; |
페이지 이동: